Incidence and Prevalence of Patients with Myelodysplastic Syndromes (MDS) in Dusseldorf 1996-2005.

被引：0
|
作者：
Neukirchen, Judith [1 ]
Schoonen, W. Marieke [2 ]
Aul, Carlo [3 ]
Haas, Rainer [1 ]
Gattermann, Norbert [1 ]
Germing, Ulrich [1 ]
机构：
[1] Univ Dusseldorf, Dusseldorf, Germany
[2] Amgen Ltd, Cambridge, England
[3] St Johannes Hosp, Med Clin 2, Duisburg, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：705 / 706
页数：2
相关论文
共 50 条
  • [41] CHARACTERIZATION OF MUTATIONS ALTERING THE PROCESS OF SPLICING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Boluda-Navarro, M.
    Liquori, A.
    Ibanez, M.
    Gonzalez-Romero, E.
    Sargas, C.
    Company, D.
    Avetisyan, G.
    Pardo-Lorente, N.
    Sanchis, D.
    Miranda, J.
    Martinez-Valiente, C.
    Llop, M.
    Morote-Faubel, M.
    San Juan-Pla, A.
    Barragan, E.
    Sanz, M. A.
    Sanz, G.
    Such, E.
    Cervera, J.
    HAEMATOLOGICA, 2018, 103 : 182 - 182
  • [42] PROGNOSTIC VALUE OF THE DUSSELDORF-SCORE IN 735 UNTREATED PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROMES
    GERMING, U
    GATTERMANN, N
    RUNDE, V
    HEYLL, A
    JAEGER, M
    SCHNEIDER, W
    AUL, C
    BLOOD, 1994, 84 (10) : A314 - A314
  • [43] Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
    Katharina Götze
    Uwe Platzbecker
    Aristoteles Giagounidis
    Detlef Haase
    Michael Lübbert
    Carlo Aul
    Arnold Ganser
    Ulrich Germing
    Wolf-Karsten Hofmann
    Annals of Hematology, 2010, 89 : 841 - 850
  • [44] Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
    Goetze, Katharina
    Platzbecker, Uwe
    Giagounidis, Aristoteles
    Haase, Detlef
    Luebbert, Michael
    Aul, Carlo
    Ganser, Arnold
    Germing, Ulrich
    Hofmann, Wolf-Karsten
    ANNALS OF HEMATOLOGY, 2010, 89 (09) : 841 - 850
  • [45] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [46] Pretreatment symptom prevalence in patients with myelodysplastic syndromes (MDS) across all disease risk categories: Analysis of 914 patients.
    Efficace, Fabio
    Niscola, Pasquale
    Patriarca, Andrea
    Cottone, Francesco
    Palumbo, Giuseppe A.
    Breccia, Massimo
    Caocci, Giovanni
    Platzbecker, Uwe
    Specchia, Giorgina
    Stauder, Reinhard
    Fianchi, Luana
    Sanpaolo, Grazia
    Petranovic, Duska
    Frairia, Chiara
    Caers, Jo
    Santini, Valeria
    Bergamaschi, Micaela
    Capodanno, Isabella
    Di Renzo, Nicola
    Vignetti, Marco
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] HIGH PREVALENCE OF ANTINUCLEAR ANTIBODIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    JAGER, U
    KALHS, P
    PANZER, S
    GRANINGER, W
    HAAS, O
    RADASZKIEWICZ, T
    PENNER, E
    NEUMANN, E
    HINTERBERGER, W
    BETTELHEIM, P
    GOSSINGER, H
    LECHNER, K
    BLUT, 1986, 53 (03): : 134 - 134
  • [48] Trends in the prevalence and incidence of diabetes in the UK: 1996-2005
    Masso Gonzalez, E. L.
    Johansson, S.
    Wallander, M-A
    Garcia Rodriguez, L. A.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2009, 63 (04) : 332 - 336
  • [49] Incidence of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) in Norway 1993-2006
    Schoonen, W.
    Aagnes, B.
    Bray, F.
    Hansen, S.
    Fryzek, J.
    Weiderpass, E.
    LEUKEMIA RESEARCH, 2009, 33 : S64 - S64
  • [50] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) in outpatient clinics - results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Welslau, M.
    Lerchenmueller, C.
    Sauer, A.
    Germing, U.
    ONKOLOGIE, 2011, 34 : 289 - 289
12345